Metoprolol Terapia

Metoprolol Tartrate, the active ingredient in Metoprolol Terapia, is a beta blocker presented as an oral tablet for oral use. It lowers blood pressure and heart workload and is prescribed for hypertension, angina, heart failure and post‑myocardial‑infarction care.

GNH USA supplies Metoprolol Terapia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol Terapia acts on the cardiovascular system to control blood pressure and heart rhythm.

Hypertension: reduces systolic and diastolic pressure to target levels. Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. Heart failure: improves ventricular function and reduces hospitalisation risk. Post‑myocardial infarction: lowers the chance of recurrent cardiac events and arrhythmias.

Metoprolol Terapia may cause a range of adverse reactions.

Common Side Effects: - Fatigue or tiredness - Dizziness, especially when standing quickly - Cold extremities or reduced peripheral circulation - Mild gastrointestinal upset such as nausea - Sleep disturbances or vivid dreams - Reduced exercise tolerance

Serious or Rare Side Effects: - Severe bradycardia or heart block - Hypotension with syncope - Worsening heart failure symptoms - Bronchospasm in patients with asthma - Depression or mood changes - Allergic reactions including rash or angioedema

Before prescribing Metoprolol Terapia, clinicians should evaluate patient history and comorbidities. - Cardiovascular assessment: review heart rate, rhythm and blood pressure. - Respiratory status: avoid in uncontrolled asthma or severe chronic obstructive pulmonary disease. - Diabetes monitoring: may mask hypoglycaemia symptoms. - Renal or hepatic impairment: adjust dosing as needed. - Concomitant medications: assess for additive bradycardic or hypotensive effects. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Metoprolol Terapia can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Non‑selective beta‑blockers: risk of excessive β‑blockade. - Calcium channel blockers (verapamil, diltiazem): may cause profound bradycardia or AV block. - Class III antiarrhythmics (e.g., amiodarone): increase plasma metoprolol levels.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: monitor for concealed hypoglycaemia. - NSAIDs or COX‑2 inhibitors: may attenuate antihypertensive effect. - Antidepressants (e.g., SSRIs): watch for additive heart‑rate slowing. - Thyroid hormones: adjust dosing if hyper‑ or hypothyroidism is present.